Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.

Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. Abstract Text:

    takeshi ichinoheTakeshi Ichinohe,akira kawaguchiAkira Kawaguchi,shin-ichi tamuraShin-ichi Tamura,hidehiro takahashiHidehiro Takahashi,hirofumi sawaHirofumi Sawa,ai ninomiyaAi Ninomiya,masaki imaiMasaki Imai,shigeyuki itamuraShigeyuki Itamura,takato odagiriTakato Odagiri,masato tashiroMasato Tashiro,joe chibaJoe Chiba,tetsutaro sataTetsutaro Sata,takeshi kurataTakeshi Kurata,hideki hasegawaHideki Hasegawa,takeshi ichinoheTakeshi Ichinohe,akira kawaguchiAkira Kawaguchi,shin-ichi tamuraShin-ichi Tamura,hidehiro takahashiHidehiro Takahashi,hirofumi sawaHirofumi Sawa,ai ninomiyaAi Ninomiya,masaki imaiMasaki Imai,shigeyuki itamuraShigeyuki Itamura,takato odagiriTakato Odagiri,masato tashiroMasato Tashiro,joe chibaJoe Chiba,tetsutaro sataTetsutaro Sata,takeshi kurataTakeshi Kurata,hideki hasegawaHideki Hasegawa,

    The avian H5N1 influenza virus has the potential to cause a new pandemic. Since it is difficult to predict which strain of influenza will cause a pandemic, it is advantageous to produce vaccines that confer cross-protective immunity. Mucosal vaccine administration was reported to induce cross-protective immunity by inducing secretion of IgA at the mucosal surface. Adjuvants can also enhance the development of fully protective mucosal immunity. Here we show that a new mucosal adjuvant, poly I:poly C12U (Ampligen), a Toll-like receptor 3 agonist proven to be safe in a Phase III human trial, is an effective adjuvant for H5N1 influenza vaccination. Intranasal administration of a candidate influenza vaccine with Ampligen resulted in secretion of IgA, and protected mice that were subsequently challenged with homologous A/Vietnam/1194/2004 and heterologous A/HK/483/97 and A/Indonesia/6/2005 virus.

    Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. Publishing Authors By Initials

    t ichinoheT Ichinohe,a kawaguchiA Kawaguchi,s tamuraS Tamura,h takahashiH Takahashi,h sawaH Sawa,a ninomiyaA Ninomiya,m imaiM Imai,s itamuraS Itamura,t odagiriT Odagiri,m tashiroM Tashiro,j chibaJ Chiba,t sataT Sata,t kurataT Kurata,h hasegawaH Hasegawa,t ichinoheT Ichinohe,a kawaguchiA Kawaguchi,s tamuraS Tamura,h takahashiH Takahashi,h sawaH Sawa,a ninomiyaA Ninomiya,m imaiM Imai,s itamuraS Itamura,t odagiriT Odagiri,m tashiroM Tashiro,j chibaJ Chiba,t sataT Sata,t kurataT Kurata,h hasegawaH Hasegawa,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Microbes and infection / Institut Pasteur

    VOLUME: 9

    Page Numbers: 1333-40

    Journal Abbreviation: Microbes Infect.

    ISSN: 1286-4579

    DAY: 1

    MONTH: 07

    YEAR: 2007

    Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100883508

    Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge.

    AFFILIATION: Department of Pathology, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama-shi, Tokyo 208-0011, Japan.

    Country: France

    France Research PublicationFrance Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Microbes Infect

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News